MIFH
BBH icon

Migdal Insurance & Financial Holdings’s VanEck Biotech ETF BBH Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-151
Closed -$16K – 459
2016
Q4 		$16K Buy
+151
New +$16.4K ﹤0.01% 376

Other funds holding BBH

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Migdal Insurance & Financial Holdings's BBH Position: Q1 2017 in Review

Migdal Insurance & Financial Holdings sold out of VanEck Biotech ETF (BBH) in Q1 2017, closing a stake of 151 shares — an estimated $16K sold.

Migdal Insurance & Financial Holdings first reported a position in BBH in Q4 2016 and held it in 1 quarter. The position peaked at $16K in Q4 2016. 79 funds tracked by Wall St. Rank hold BBH as of Q1 2017.

  • Migdal Insurance & Financial Holdings reported no remaining VanEck Biotech ETF position as of Q1 2017 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 151 VanEck Biotech ETF shares in Q1 2017, an estimated $16K.
  • Migdal Insurance & Financial Holdings first reported a position in VanEck Biotech ETF in Q4 2016 and held it in 1 quarter.
  • Migdal Insurance & Financial Holdings's VanEck Biotech ETF position peaked at $16K in Q4 2016.
  • 79 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2017.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2017, filed 15 May 2017.